TD Asset Management
ABEO icon

TD Asset Management’s Abeona Therapeutics ABEO Stock Holding History

TD Asset Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,083
Closed -$383K – 1323
2019
Q1 		$383K Sell
2,083
-228
-10% -$40.8K ﹤0.01% 1231
2018
Q4 		$413K Sell
2,311
-1,077
-32% -$235K ﹤0.01% 1258
2018
Q3 		$1.08M Buy
3,388
+120
+4% +$42.6K ﹤0.01% 1139
2018
Q2 		$1.31M Buy
3,268
+1,968
+151% +$860K ﹤0.01% 1061
2018
Q1 		$466K Buy
1,300
+712
+121% +$265K ﹤0.01% 1217
2017
Q4 		$233K Buy
+588
New +$243K ﹤0.01% 1289

Other funds holding ABEO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TD Asset Management's ABEO Position: Q2 2019 in Review

TD Asset Management sold out of Abeona Therapeutics (ABEO) in Q2 2019, closing a stake of 2,083 shares — an estimated $383K sold.

TD Asset Management first reported a position in ABEO in Q4 2017 and held it in 6 quarters. The position peaked at $1.31M in Q2 2018. 98 funds tracked by Wall St. Rank hold ABEO as of Q2 2019.

  • TD Asset Management reported no remaining Abeona Therapeutics position as of Q2 2019 after selling out during the quarter.
  • TD Asset Management sold 2,083 Abeona Therapeutics shares in Q2 2019, an estimated $383K.
  • TD Asset Management first reported a position in Abeona Therapeutics in Q4 2017 and held it in 6 quarters.
  • TD Asset Management's Abeona Therapeutics position peaked at $1.31M in Q2 2018.
  • 98 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2019.

Based on TD Asset Management's 13F filing for Q2 2019, filed 1 Aug 2019.